Currently completing his honours in science at the institute, Sargun is interested in studying novel and new methods to treat diabetes. Having been exposed to diabetes research over the course of his undergraduate studies, where he investigated the role of novel antigens in type 1 diabetes development to better understand the disease. Sargun is hoping to continue research into type 1 diabetes and gain experience in how therapeutic solutions are being researched and generated.

The Epigenetics in Human Health and Disease laboratory has been applying epigenetic techniques to generate cutting-edge new therapeutic solutions to diabetes and other metabolic conditions. Through application of EZH2 inhibition the laboratory has demonstrated the ability to regenerate β-like-cells, this would end the reliance of millions of patients type 1 diabetes on exogenous insulin for survival and represents a potential cure for the condition. 

Under the guidance of Professor Sam El-Osta and Dr Ram Abou Zaki MD, Sargun will investigate the regenerative potential of pancreatic stellate cells to aid in development of a potential therapeutic and shed some light on an underutilised and researched pancreatic cell. Providing guidance on the next steps in developing an epigenetic cure for type 1 diabetes.